DAPK1 and transitional cell carcinoma: Transitional cell carcinoma patients had median NIM levels of 58% in the younger group and 65% in the older group for APAF-1, the corresponding levels being 16 and 10%, respectively for DAPK-1 (P=0.4 and=0.8).